ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 29081663

Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis.

Zhuan-Sun Y and 6 others. Onco Targets Ther, 2017. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis. Papers, record 29081663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29081663

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis.
PubMed
Journal
Onco Targets Ther
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2022-04-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhuan-Sun YYongxun
2Huang FFengting
3Feng MMin
4Zhao XXinbao
5Chen WWenying
6Zhu ZZhe
7Zhang SShineng

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127,059,987Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer.J Gastroenterol Hepatol2016https://conductscience.org/library/papers/27059987PubMed
221,918,895Dual biological effects of the cytokines interleukin-10 and interferon-γ.Cancer Immunol Immunother2011https://conductscience.org/library/papers/21918895PubMed
326,562,534High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma.PLoS One2015https://conductscience.org/library/papers/26562534PubMed
427,342,842NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells.J Immunol2016https://conductscience.org/library/papers/27342842PubMed
523,359,812Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.PLoS One2013https://conductscience.org/library/papers/23359812PubMed
617,555,582Practical methods for incorporating summary time-to-event data into meta-analysis.Trials2007https://conductscience.org/library/papers/17555582PubMed
724,378,899Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer.Oncol Rep2014https://conductscience.org/library/papers/24378899PubMed
827,932,443PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy.EMBO Mol Med2017https://conductscience.org/library/papers/27932443PubMed
926,024,796PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.Lung Cancer2015https://conductscience.org/library/papers/26024796PubMed
1024,175,978Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.Eur J Haematol2014https://conductscience.org/library/papers/24175978PubMed

1 to 10 of 55

See all 55 references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
39,539,267Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients.ACS Pharmacol Transl Sci2024https://conductscience.org/library/papers/39539267PubMed
38,954,689Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics.PLoS One2024https://conductscience.org/library/papers/38954689PubMed
37,313,463Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing.Front Oncol2023https://conductscience.org/library/papers/37313463PubMed
36,678,734An Efficient, Short Stimulus PANC-1 Cancer Cell Ablation and Electrothermal Therapy Driven by Hydrophobic Interactions.Pharmaceutics2022https://conductscience.org/library/papers/36678734PubMed
35,392,221A Novel Sushi-IL15-PD1 CAR-NK92 Cell Line With Enhanced and PD-L1 Targeted Cytotoxicity Against Pancreatic Cancer Cells.Front Oncol2022https://conductscience.org/library/papers/35392221PubMed
34,876,919Comparison of programmed death ligand 1 immunostaining for pancreatic ductal adenocarcinoma between paired cytological and surgical samples.Cytojournal2021https://conductscience.org/library/papers/34876919PubMed
34,206,937MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34206937PubMed
34,108,626Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer.Sci Rep2021https://conductscience.org/library/papers/34108626PubMed
33,204,397Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.Oxid Med Cell Longev2020https://conductscience.org/library/papers/33204397PubMed
32,676,968Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer.Virchows Arch2021https://conductscience.org/library/papers/32676968PubMed

1 to 10 of 22

See all 22 cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD27680,381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IFNG3,458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103,586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
PDCD15,133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
STAT16,772PubTator's text mininghttps://conductscience.org/library/genes/6772NCBI Gene
STAT36,774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene
TENM110,178PubTator's text mininghttps://conductscience.org/library/genes/10178NCBI Gene
VEGFA7,422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29081663

GET https://conductscience.org/api/papers/v1/29081663/references?page=2

API referenceFor AI assistants